Pre-Market Overview: November 23, 2025

Pre-market futures signal a strong open for U.S. indices, with the NASDAQ-100 up +1.97% led by tech momentum from Nvidia’s earnings beat. Treasury Secretary Scott Bessent’s reassurance of no 2026 recession and robust consumer spending (Wicked sequel’s $150M debut) support risk-on sentiment. Healthcare and industrials sectors lead early gains, while utilities lag.

• Overnight Global Markets
  : Asian markets surged on Nvidia’s earnings beat [3], and European STOXX50 rose +0.3% amid Fed policy signals [3].
• Pre-Market Futures
  : NASDAQ-100 Pre Market Indicator is up +1.97% (25,126.57, +486.05) [4], S&P500 futures up +0.33% [4], Dow futures up +0.27% [4].
• Recent Index Performance
  : As of Nov21 close, Russell2000 (+2.72%) led gains, followed by Dow (+0.95%), S&P500 (+0.72%), and NASDAQ (+0.50%) [0].
• Sector Trends
  : Healthcare (+1.73%) and Industrials (+1.52%) are top performers; Utilities (-0.88%) are the only declining sector [0].

1. Recession Reassurance
   : Treasury Secretary Scott Bessent stated the U.S. will avoid a recession in 2026, citing upcoming benefits from Trump’s policies (tax cuts, SALT deduction) and noting challenges in housing and interest-sensitive sectors [1]. He also teased upcoming healthcare affordability measures [1].
2. Tech & AI Momentum
   : Nvidia’s earnings beat lifted global tech sentiment, driving pre-market NASDAQ gains [3][7]. Curated news highlights concerns over AI trade sustainability despite Nvidia’s strength [7].
3. Consumer Spending
   : The Wicked sequel’s $150M weekend debut signals robust consumer cyclical activity [2], supporting the sector’s +1.37% gain [0].
4. Global Spillover
   : Asian markets surged on Nvidia’s results, and European stocks benefited from Fed policy optimism [3].

• Tech
  : Nvidia (NVDA) is expected to lead pre-market gains (driving NASDAQ futures) [3][7].
• Consumer Cyclical
  : Cinema chains (e.g., AMC) may benefit from the Wicked sequel’s strong box office [2].
• Healthcare
  : Pharma stocks (e.g., Roche, AstraZeneca) lead sector gains [0][3].

• Today’s Economic Data
  : No major U.S. economic releases scheduled [5].
• Upcoming Earnings
  : Zoom (Nov24), Alibaba (Nov25), Deere (Nov26) are key reports [6].
• Technical Levels
  : Watch S&P500 resistance at 6,660 (Nov21 high) [0] and NASDAQ resistance at 22,531 (Nov21 high) [0].
• Risks
  : Utilities underperformance may signal rate concerns; housing sector struggles (per Bessent) require monitoring [0][1].

Disclaimer

: This analysis is for informational purposes only and not investment advice. All data is sourced from publicly available tools and should be verified before making decisions.

Timestamp

: November23,2025 08:30 EST (pre-market)

Compliance

: Not investment advice; for decision-making context only.

Prepared by Market Overview Analyst
Source: Ginlix AI & Public Data Feeds
©2025 Ginlix Inc.
All rights reserved.

Critical Note

: Pre-market data is volatile and may change before the opening bell. Monitor real-time feeds for updates.

Risk Warning

: Past performance does not guarantee future results. Always conduct independent research before investing.

Last Updated: November23,2025 08:30 EST
Contact: analysis@ginlix.com
Terms of Use: https://ginlix.com/terms
Privacy Policy: https://ginlix.com/privacy

Disclosure

: No conflicts of interest declared for this analysis.

Data Accuracy

: All data is as of the time of writing and subject to revision.

Version: 1.0
Build: 2025.11.23
License: For internal use only

End of Document